We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automated Workstation Screens Urine Before Culture

By LabMedica International staff writers
Posted on 20 Feb 2013
Automated systems have been developed to screen urine in order to eliminate those in which a culture is highly unlikely to yield clinically relevant results.

A flow cytometry system that quantifies urine elements associated with urinary tract infection (UTI) has recently added a new element, the detection of “all small particles” (ASP) to improve the sensitivity of the assay.

Scientists at the Veterans Affairs Medical Center (Houston, TX, USA) evaluated 1,000 urine specimens submitted consecutively that had a urine culture and urinalysis ordered on the same day. More...
Specimens were tested for leukocyte esterase and nitrite with a chemistry dipstick analyzer and for white blood cells (WBC), ASP, bacteria, and yeast with an automated urinalysis system. Urinary samples were also tested on bacterial culture plates.

There were 893 samples from male patients, and 107 from females. There were 123 specimens from patients with indwelling urinary catheters. Of the 1,000 specimens evaluated 604 (60.4%) were culture positive at any level, that is equal to or greater than 103 colony forming units (CFU)/mL. Two combinations of results available on the iQ200 Workstation (Iris Diagnostics; Chatsworth, CA, USA) were assessed for sensitivity, specificity, and negative predictive value (NPV).One method assessed leukocyte esterase, WBCs, nitrite, and the presence of few or more bacteria or yeast, a combination chosen to reflect the current parameters combination of manual urinalysis strips and standard microscopy. The other method assessed WBCs, the presence of few or more bacteria or yeast, and an ASP count of greater than 10,000, thus eliminating the redundancy of biochemical markers and focusing on the microscopic elements available on the iQ200.

The iQ200 Workstation is used in combination with the Aution Max AX-4280 chemistry dipstick analyzer (Arkray; Edina, MN, USA). The scientists found that the dipstick analysis added no advantage in a laboratory with microscopy. Although specificities were generally low, between 65.6% and 70.1%, the goal for screening samples is high sensitivity and NPV. The NPV approached 95% in comparison to the gold standard, but was further improved to greater than 99% when compared to the ordering clinician's diagnosis or an expert review that assessed the indications in the record that a UTI was present. The authors concluded that ASP did not enhance specificity, sensitivity, or NPV. The iQ200 Workstation performed well by any standard, thus providing a reliable system by which to improve the use of laboratory resources. The study was published in the January 2013 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Veterans Affairs Medical Center
Iris Diagnostics
Arkray



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.